Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation

Keyphrases

• Superoxide Dismutase 1 (SOD1) 100%
• Amyotrophic Lateral Sclerosis 100%
• Selective Formation 100%
• Advanced Glycation End Products 100%
• Spinal Astrocytes 100%
• Lysine 60%
• Immunoreactivity 60%
• Transgenic Mice 40%
• Spinal Cord 40%
• Carbonyl Stress 40%
• Advanced Lipoxidation End Products 40%
• Age-matched 20%
• Motor Neuron Degeneration 20%
• Transgenic Mouse Model 20%
• Protein Glycation 20%
• SOD1G93A 20%
• Malondialdehyde 20%
• Lipid Peroxidation 20%
• Mutant Superoxide Dismutase 1 20%
• Reactive Astrocytes 20%
• Immunohistochemical Investigation 20%
• Acrolein 20%
• 4-hydroxy-2 20%
• Pentosidine 20%
• N-carboxymethyllysine 20%
• Argpyrimidine 20%
• Pyrraline 20%

Neuroscience

• Copper Zinc Superoxide Dismutase 100%
• Advanced Glycation End Product 100%
• Astrocyte 100%
• Amyotrophic Lateral Sclerosis 66%
• Lysine 50%
• N(6)-Carboxymethyllysine 16%
• Nerve Cell Degeneration 16%
• Protein Glycosylation 16%
• Pentosidine 16%
• Motor Neuron 16%
• Lipid Peroxidation 16%